Sign Up to like & get
recommendations!
1
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz126.353
Abstract: CPG2 is an efficient rescue recombinant bacterial enzyme that cleaves MTX into inactive metabolites. As hdMTX is the key agent in PCNSL, delayed MTX excretion (DME), and/or MTX induced nephrotoxicity (MIN) may expose the patients…
read more here.
Keywords:
loc network;
cpg2;
study;
rescue ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "BioMed Research International"
DOI: 10.1155/2020/3687134
Abstract: Purpose The study was aimed at assessing renal functions of children with acute lymphoblastic leukemia (ALL) after induction therapy by 99mTc-DTPA renal dynamic imaging Gates method (GFRGates) and investigating whether renal function after induction therapy…
read more here.
Keywords:
hdmtx induced;
renal function;
induction therapy;
hdmtx ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of the Egyptian National Cancer Institute"
DOI: 10.1186/s43046-022-00122-7
Abstract: Repeated high-dose methotrexate (HDMTX) is a critical component of contemporary childhood acute lymphoblastic leukemia (ALL) treatment regimens. Serum albumin is considered a carrier of methotrexate (MTX) in the blood. Hypoalbuminemia is not a rare finding…
read more here.
Keywords:
hdmtx;
infusion;
serum albumin;
risk ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15051459
Abstract: Simple Summary High-dose methotrexate (HDMTX) is the backbone of induction therapy for primary central nervous system lymphoma (PCNSL). There are numerous different protocols to treat PCNSL that incorporate a wide range of HDMTX doses and…
read more here.
Keywords:
hdmtx;
primary central;
central nervous;
dose methotrexate ... See more keywords